Artificial Intelligence–Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study

Sanja Đačić, William D. Travis, Jennifer M. Giltnane, Filip Kos, John H. Abel, Stephanie Hilz, Junya Fujimoto, Lynette M. Sholl, J. Ritter, Farah Khalil, Yi Liu, Amaro Taylor‐Weiner, Murray B. Resnick, Hui Yu, Fred R. Hirsch, Paul A. Bunn, David P. Carbone, Valerie W. Rusch, David J. Kwiatkowski, Bruce E. Johnson, Jay M. Lee, Stephanie Hennek, Ilan Wapinski, Alan Nicholas, Ann Johnson, Katja Schulze, Mark G. Kris, Ignacio I. Wistuba